TABLE 2.
Cardio-cerebrovascular diseases | Starting date for follow-up of the controls (June 4, 2020) |
Ischemic heart disease I20–I25 | |
Adjusted IRR (95 CI)* | 1.78 (1.57–2.02) |
Adjusted IRR (95 CI)† | 1.60 (1.36–1.85) |
Adjusted HR (95 CI)‡ | 3.02 (2.19–4.17) |
Cerebral hemorrhage I60–I62 | |
Adjusted IRR (95 CI)* | 2.06 (1.25–3.40) |
Adjusted IRR (95 CI)† | 2.02 (1.09–3.73) |
Adjusted HR (95 CI)‡ | 4.08 (0.90–19.19) |
Cerebral infarction I63 | |
Adjusted IRR (95 CI)* | 1.08 (0.84–1.40) |
Adjusted IRR (95 CI)† | 0.96 (0.71–1.30) |
Adjusted HR (95 CI)‡ | 1.29 (0.54–3.07) |
IRR, incidence rate ratio; HR, hazard ratio. *Adjusted for age and sex. †Adjusted for age, sex, residence area and income level. ‡Adjusted for demographic variables, health behaviors, anthropometric values, and covariates.